Respiratory Pathogens
Rapid Detection of Respiratory Pathogens
HealthTrackRx (HTRx) is the premier specialty diagnostic laboratory dedicated to the detection of infectious diseases.
With a decades-long track record of industry-leading technological advancement, our assays deliver accurate, actionable data with best-in-class turnaround time.
99% of samples received by our lab are reported out within 24-36 hours of receipt.
Eliminate the Guesswork in Diagnosis and Treatment
Our RPP pathogen assay utilizes the latest in quantitative RT-PCR technology to rapidly and reliably analyze your patient’s sample.
We rapidly detect and differentiate 99% of the most relevant bacterial, viral, and fungal targets, including Influenza, COVID-19, Haemophilus influenza, Streptococcus pneumoniae and Staphylococcus aureus.
Our molecular technique provides a more definitive diagnosis than POC antigen assays and conventional culture*
Our Respiratory Diagnostics:
- Reduce false negatives
- Detect polymicrobial infections
- Are unaffected by concurrent antibiotic use
- Include one of the most extensive antibiotic resistance gene panels
- Reduce unnecessary drug exposure and adverse events
- Report within 24-36 hours of sample receipt
Prescribe with Confidence
As the leader in testing sensitivity and specificity, our reports include a custom-designed accurate and detailed antibiogram.
- Support antibiotic stewardship by reducing over-utilization of broad-spectrum anti-infectives
- Decrease the need for empiric therapy
- Reduce unnecessary drug exposure, adverse events, cost of repeat testing, and multiple treatment attempts
The New 99%
Over 99% of results are reported within 24-36 hours of sample receipt
Over 99% sensitivity to reduce false positives
Over 99% specificity to reduce false positives
Over 99% of the most common pathogens detected
100% trackable samples and results
Learn More
(940) 383-2223 | [email protected] | www.healthtrackrx.com
Respiratory Pathogens
- Acinetobacter baumanii
- Adenovirus HAdV-B
Aspergillus flavus, fumigatus, niger, terreus
- Bordetella pertussis, parapertusis, bronchiseptica
- Candida albicans, glabrata, parapsilosis, tropicalis
Candida auris
- Chlamydia tracomatis
- Chlamydophila pneumoniae
- Coronavirus (229E, NL63, )C43, and HKU1)
COVID-19 Coronavirus (SARS-CoV-2)
- Escherichia coli
- Enterobacter aerogenes, cloacae
- Enterovirus A+B+C
- Enterovirus D
- Haemophillus influenzae
- Varicella zoster virus (Human Herpes Virus 3)
- Human metapneumovirus
- Influenza virus A,B probes
- Klesiella 'pneumoniae', ooxytoca
- Legionella pneumophila
- Moraxella catarrhalis
- Mycoplasma pneumoniae
- Mycobacterium avium-intracellulare, kansasii
- Neisseria gonorrhoeae
- Parainfluenza virus (types 1, 2, 3, 4)
- Proteus mirabilis, vulgaris
- Pseudomonas aeruginosa
- Respiratory syncytial virus
- Rhinovirus A+B+C
- Rhizopus spp, Mucor spp.
- Serratia marcescens
- Staphylococcus aureus
- Staphylococcus spp
- Streptococcus agalactiae (Group B strep (GBS))
- Streptococcus pneumoniae
- Steptococcus pyogenes (Group A strep)
Antibiotic Resistance Genes
- VanA, VanB (Vancomycin resistance)
- ermB, C; mefA (Macrolide Lincosamide Streptogramin)
- SHV, KPC Groups (Class A beta lactamase)
- dfr (A1, A5), sul (1, 2) probes (Trimethoprim/Sulfamethoxazole resistance)
- mecA (Methicillin gene)
- qnrA1, qnrA2, qnrB2 (Fluoroquinolone genes)
- tet B, tet M (Tetracycline genes)
- IMP, NDM, VIM Groups (Class B metallo beta lactamase)
- ACT, MIR, FOX, ACC Groups (AmpC beta lactamase)
- OXA-48,-51 (Class D oxacillinase)
- CTX-M1 (15), M2 (2), M9 (9), M8/25 Groups (Class A beta lactamase)
*Rhoads, D., Wolcott, R., Sun, Y., Dowd, S. (23 February 2012). Comparison of culture and molecular identification of bacteria in chronic wounds. Int. J. Mol. Sci., 13, 2535-2550. Retrieved from www.mdpi.com/journal.ijms
Learn More
Ready to improve outcomes with fast, accurate diagnostic results? Contact us to learn more.
Click below to schedule your consultation.